8-K: KindlyMD Reports Q3 2025 Results, Advances Bitcoin Strategy

Sentiment:

Quarterly Financial Results and Strategic Update


KindlyMD, Inc. announced its third-quarter 2025 financial results, highlighting a significant net loss driven by its Bitcoin treasury strategy and the completed merger with Nakamoto.

Capital raiseRaised approximately $540 million of gross proceeds from a private placement in May 2025.Raised $200 million in convertible notes in May 2025.Established a $5 billion at-the-market (ATM) equity offering program.Raised $5.6 million through the ATM program at an average share price of $4.15.
Worse than expectedNet loss significantly increased to $86.0 million in Q3 2025 from $1.0 million in Q3 2024.Revenue decreased to $0.4 million in Q3 2025 from $0.6 million in Q3 2024.Operating expenses surged to $10.8 million in Q3 2025 from $1.7 million in Q3 2024.The company incurred a $22.1 million unrealized loss on digital assets, indicating a decline in the value of its Bitcoin holdings during the quarter.A $59.8 million non-cash charge related to the acquisition of Nakamoto also contributed to the increased loss.

Summary

  • KindlyMD, Inc. reported a net loss of $86.0 million, or $(0.42) per diluted share, for Q3 2025, a substantial increase from a $1.0 million net loss, or $(0.17) per diluted share, in Q3 2024.
  • The increased net loss was primarily due to a $59.8 million non-cash charge from the Nakamoto acquisition and a $22.1 million non-cash unrealized loss on digital assets.
  • Total revenue for Q3 2025 was $0.4 million, down from $0.6 million in Q3 2024, reflecting results from its healthcare business.
  • Operating expenses surged to $10.8 million in Q3 2025 from $1.7 million in Q3 2024, driven by increased SG&A costs related to the new Bitcoin strategy.
  • The company completed its merger with Nakamoto Holdings, Inc., establishing it as a wholly-owned subsidiary.
  • As of September 30, 2025, KindlyMD had purchased 5,765 Bitcoin at a weighted average price of $118,204.88, totaling approximately $681 million.
  • The company held 5,398 Bitcoin as of November 12, 2025, after utilizing 367 Bitcoin for strategic investments.
  • Strategic investments include a $15 million investment in Treasury BV (Netherlands) and a $30 million investment in Metaplanet Inc. (Japan), with an additional $6 million investment in FUTURE Holdings AG (Switzerland) in November 2025.
  • KindlyMD established a $5 billion at-the-market (ATM) equity offering program, raising $5.6 million at an average share price of $4.15.
  • Amanda Fabiano was appointed Chief Operating Officer to lead the execution of the Bitcoin strategic roadmap.

Sentiment

Score: 3

Explanation: While the company successfully executed its strategic shift to a Bitcoin treasury model and made several key investments and appointments, the financial results for Q3 2025 show a significant deterioration in profitability, driven by substantial losses related to the acquisition and unrealized losses on digital assets, alongside declining core healthcare revenue and soaring operating expenses. The strategic progress is overshadowed by the immediate negative financial impact.

Positives

  • Successful completion of the merger with Nakamoto Holdings, Inc., establishing a Bitcoin treasury company.
  • Accumulation of a significant Bitcoin treasury, with 5,398 Bitcoin held as of November 12, 2025.
  • Strategic investments in three Bitcoin-focused companies: Treasury BV ($15 million), Metaplanet Inc. ($30 million), and FUTURE Holdings AG ($6 million).
  • Execution of an agreement for a call option to purchase BTC Inc., creating a pathway to add media, advisory, and financial services.
  • Establishment of a $5 billion ATM equity offering program, which has already raised $5.6 million, enhancing capital-raising flexibility.
  • Appointment of Amanda Fabiano as COO, bringing extensive experience in Bitcoin finance and capital markets.

Negatives

  • Significant increase in net loss to $86.0 million in Q3 2025 from $1.0 million in Q3 2024.
  • Substantial non-cash charge of $59.8 million related to the acquisition of Nakamoto.
  • A $22.1 million non-cash unrealized loss on digital assets.
  • A $1.4 million realized loss on digital assets from Bitcoin sold to fund investments.
  • Total revenue decreased to $0.4 million in Q3 2025 from $0.6 million in Q3 2024, indicating a decline in the core healthcare business.
  • Operating expenses increased dramatically to $10.8 million in Q3 2025 from $1.7 million in Q3 2024, primarily due to SG&A costs associated with the new Bitcoin strategy.
  • Diluted net loss per share worsened to $(0.42) in Q3 2025 from $(0.17) in Q3 2024.

Risks

  • Bitcoin market volatility.
  • Cybersecurity and custody risks associated with digital assets.
  • Potential changes in laws or accounting standards related to cryptocurrency.
  • Regulatory developments affecting Bitcoin or other digital assets.
  • Adverse effects on the market value of securities due to changes in the company's capital structure and governance.
  • Challenges in retaining customers, key personnel, and maintaining relationships with suppliers and customers.
  • Risk of inability to reduce expenses or access financing or liquidity.
  • Impact of any related economic downturn.
  • Changes in governmental regulations or enforcement practices.
  • Adverse impacts from geopolitical events, health crises, supply chain disruptions, cybersecurity threats, data breaches, intellectual property disputes, competitive pressures, or changes in consumer behavior.

Future Outlook

The company aims to build a durable Bitcoin-native operating platform by accumulating and holding a significant Bitcoin treasury, allocating a portion for strategic investments, and acquiring recurring-revenue, cash-generating Bitcoin-related businesses to fund further Bitcoin accumulation and ecosystem growth. Management emphasizes disciplined execution, integrating high-quality, cash-generating businesses to compound value and translate expected growth into sustainable returns for shareholders. They plan to prioritize investments in enterprises aligned with their long-term vision and use earnings to support Bitcoin accumulation and strategic opportunities.

Management Comments

  • "We set clear goals—merge our companies, establish a Bitcoin treasury, and begin investing strategically—and we delivered on all three." David Bailey, Chairman and CEO.
  • "We’ve executed against every goal put in place this quarter, and created a strong foundation to build a long-term Bitcoin treasury company designed to thrive through every market cycle." David Bailey, Chairman and CEO.
  • "Our Bitcoin treasury isn’t a passive reserve. Its a strategic tool. By selectively investing in and acquiring companies that strengthen the broader Bitcoin ecosystem and support our operating goals, we aim to compound long-term shareholder value while reinforcing the foundation of our business." Tyler Evans, CIO.
  • "Our focus is on disciplined execution—integrating high-quality, cash-generating businesses into a unified Bitcoin operating platform that compounds value over time." Amanda Fabiano, Chief Operating Officer.
  • "We are building the foundation necessary to translate that expected growth into sustainable returns for shareholders." Amanda Fabiano, Chief Operating Officer.

Industry Context

This announcement positions KindlyMD as a hybrid entity, combining its original healthcare services with a significant new venture into Bitcoin treasury management and ecosystem development. This strategy aligns with a growing trend of public companies, notably MicroStrategy, adopting Bitcoin as a primary treasury asset and actively investing in the broader crypto ecosystem. By acquiring Bitcoin-related businesses and making strategic investments, KindlyMD is attempting to create a diversified revenue stream and asset base, moving beyond traditional corporate treasury management to actively participate in the growth of the Bitcoin economy. The appointment of a COO with extensive Bitcoin finance experience further signals a serious commitment to this new direction, aiming to leverage industry expertise for strategic M&A and growth initiatives.

Comparison to Industry Standards

  • The company's strategy of accumulating Bitcoin as a primary treasury asset and investing in Bitcoin-focused companies is comparable to MicroStrategy, which pioneered this corporate strategy. MicroStrategy holds a significantly larger Bitcoin treasury (over 200,000 BTC as of early 2024) and has also engaged in strategic investments and software development within the Bitcoin space.
  • KindlyMD's acquisition of 5,765 Bitcoin at a weighted average price of $118,204.88 positions it as a notable, though smaller, player compared to MicroStrategy.
  • Investments in companies like Metaplanet Inc. (Japan) and Treasury BV (Netherlands) indicate a global approach to building a Bitcoin ecosystem, similar to how larger tech companies might acquire startups to expand their market reach or technological capabilities. Metaplanet Inc. itself is a publicly traded Japanese company that has adopted a Bitcoin treasury strategy, making it a direct comparable in terms of strategic direction, though not necessarily scale.
  • The establishment of a $5 billion ATM equity offering program is a common capital-raising tool for growth companies, but its application here specifically for Bitcoin accumulation and strategic initiatives highlights the unique nature of KindlyMD's new business model.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Operating OfficerNAAmanda FabianoQ3 2025To lead execution of the company's strategic roadmap, bringing a decade of experience in Bitcoin finance and capital markets.

Stakeholder Impact

  • Shareholders: Significant dilution due to increased shares outstanding (from 5.9M to 203M weighted average shares) and the ATM program. Potential for long-term value creation through Bitcoin strategy, but immediate negative impact from substantial net losses and unrealized losses on digital assets.
  • Employees: New COO appointment indicates a focus on strategic execution, potentially impacting roles and responsibilities within the new hybrid structure.
  • Customers (Healthcare): The core healthcare business revenue declined, suggesting potential impact on service delivery or market share, though the focus has shifted.
  • Creditors: The company raised $200 million in convertible notes, increasing its debt obligations.
  • Bitcoin Ecosystem: The company's strategic investments in other Bitcoin-focused companies (Treasury BV, Metaplanet Inc., FUTURE Holdings AG) and the call option for BTC Inc. indicate a positive impact on the broader Bitcoin industry by providing capital and fostering growth.

Next Steps

  • Continue to build a durable Bitcoin-native operating platform.
  • Further accumulate Bitcoin in its treasury.
  • Allocate a portion of the treasury for strategic investments in Bitcoin-focused public companies and treasury assets.
  • Lay the foundation to acquire recurring-revenue, cash-generating Bitcoin-related businesses.
  • Integrate high-quality, cash-generating businesses into a unified Bitcoin operating platform.
  • Prioritize investments in enterprises aligned with the long-term vision.
  • Use earnings to support Nakamoto's efforts to accumulate Bitcoin and reinvest in strategic opportunities.

Key Dates

DateDescription
2019KindlyMD, Inc. was formed.
May 2025KindlyMD announced its merger with Nakamoto Holdings, Inc. and raised approximately $540 million from a private placement and $200 million in convertible notes.
August 2025KindlyMD completed its merger with Nakamoto Holdings Inc.
September 30, 2025End of the fiscal quarter for which financial results are reported; company had purchased 5,765 Bitcoin cumulatively; enterprise value was $635,885,949; 427,152,834 shares and 84,502,113 prefunded warrants outstanding.
November 12, 2025Company held 5,398 Bitcoin.
November 14, 2025439,850,889 shares and 71,704,975 prefunded warrants outstanding.
November 19, 2025Date of the press release announcing Q3 2025 results and date of the 8-K filing.

Recommendation

sell

The company's Q3 2025 financial results are significantly worse than the prior year, with a massive increase in net loss driven by non-cash charges from the Nakamoto acquisition and substantial unrealized losses on digital assets. Revenue from the core healthcare business is declining, while operating expenses have surged. Although the company has made strategic progress in establishing its Bitcoin treasury and making investments, the immediate financial performance is highly concerning. The significant dilution from increased shares outstanding and the ongoing ATM program, combined with the volatility inherent in its new Bitcoin treasury strategy, presents substantial risks. Given the deteriorating financial health and the speculative nature of its new primary business, a seasoned investor would likely recommend selling to mitigate further downside risk until there is clear evidence of improved financial performance and a stable, profitable Bitcoin strategy.

Keywords

Bitcoin treasury, KindlyMD, Nakamoto Holdings, Q3 2025 financial results, digital assets, cryptocurrency investments, healthcare services, NASDAQ: NAKA, Bitcoin ecosystem, strategic investments, ATM equity offering, corporate governance, financial reporting, SEC filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.